Skip to evidence report

T.CD8_transitional.APC_like: Studies

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 6,230 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 1–1,000 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for T.CD8_transitional.APC_like
#Trait / studyIndividual trait IDMean IC score
1Nasal polypFING0000085863.20
2TXNL1 levelsGCST9047099357.56
3CXCL9 levelsGCST9046893554.99
4Chronic sinusitisFING0000029854.82
5Second line medication for Crohn's diseaseFING0000128453.93
6Psoriasis vulgaris (PheCode 696.41)GCST9047619053.07
7Lymphocyte countGCST9002598453.07
8CRTAM/VCAM1 ratioGCST9031428153.05
9Psoriatic arthritisGCST9024395652.17
10GZMA/GZMH ratioGCST9031500851.12
11Lymphoid neoplasms (somatic mutation group 2 phenocluster)GCST9062475050.96
12RBFOX3 levelsGCST9047043250.90
13TNFRSF8 levelsGCST9047091550.29
14Psoriasis (PheCode 696.4)GCST9047618749.58
15Lymphocyte countGCST9001874249.56
16FCRL6 levelsGCST9046920949.42
17Allergic contact dermatitisFING0000006849.22
18MS-disease / Multiple SclerosisFING0000083949.13
19Multiple sclerosisGCST9047583348.37
20Psoriasis and related disorder (PheCode 696)GCST9047618648.09
21Lymphoid neoplasms (B-cell phenocluster)GCST9062473647.90
22IL15 levelsGCST9046955647.62
23PAFAH1B3 levelsGCST9047014547.46
24CXCL16 levelsGCST9046892847.08
25Lymphocyte countGCST9000231747.07
26IFNG levelsGCST9046951546.96
27Suggestive for eosinophilic asthmaFING0000134445.19
28GNLY levelsGCST9046937245.05
29Papulosquamous disordersFING0000114444.74
30CD244/CRTAM ratioGCST9031376343.94
31PsoriasisGCST9001901643.73
32lymphocyte (absolute count, maximum, inv-norm transformed)GCST9047542343.25
33lymphocyte (absolute count, mean, inv-norm transformed)GCST9047542643.23
34Lymphoid neoplasmsGCST9062474342.68
35Type 1 diabetesGCST9001379142.66
36ITGAL levelsGCST9046963742.64
37NCR1 levelsGCST9047000942.29
38RPE levelsGCST9047049542.09
39Lymphoid neoplasms (drug group 1 phenocluster)GCST9062474041.60
40CD8A levelsGCST9046865541.22
41CD48/CRTAM ratioGCST9031383940.80
42Reimbursement for rheumatic diseasesFING0000124740.78
43Asthma-related infectionsFING0000011840.45
44lymphocyte (absolute count, minimum, inv-norm transformed)GCST9047542940.21
45HyperthyroidismGCST9046813639.78
46Rheumatoid arthritisFING0000126739.76
47Lymphocyte count (UKB data field 30120)GCST9046808239.26
48GNLY/GZMA ratioGCST9031494938.97
49lymphocyte (fraction, maximum, inv-norm transformed)GCST9047543238.92
50Mouth/teeth dental problems - Mouth ulcers | MouthUKBB0000048838.84
51Type 1 diabetesGCST9000052938.80
52IDO1 levelsGCST9046950638.36
53GZMH levelsGCST9046942538.02
54Pain type(s) experienced in last month - Pain all over the body | PainUKBB0000063237.81
55CD160/KLRB1 ratioGCST9031373137.68
56Asthma | respiratoryUKBB0000005437.36
57Asthma | Chronic lower respiratory diseasesUKBB0000005337.26
58LTA levelsGCST9046981337.23
59CD5/TNFRSF9 ratioGCST9031386236.88
60CD160/CXCL16 ratioGCST9031372836.34
61Seropositive rheumatoid arthritis, wideFING0000129836.28
62CXCL10 levelsGCST9046892336.27
63Lymphocyte countGCST9000231636.17
64Lymphocyte countGCST9000238836.02
65GZMA/GZMB ratioGCST9031500735.70
66Left-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030270635.68
67Lichen ruber planus, wide definition including periferal and oral lichen planusFING0000072235.64
68Thyroid peroxidase antibody positivity in pregnancyGCST9043520235.62
69Atopic dermatitisFING0000012535.36
70HLAE/IL15 ratioGCST9031506135.25
71Seropositive rheumatoid arthritis, strict definitionFING0000129734.94
72CD160/NCR1 ratioGCST9031373234.78
73eosinophil (absolute count, mean, inv-norm transformed)GCST9047529134.71
74Rheumatoid arthritisGCST9013222334.64
75CRTAM/FCRL6 ratioGCST9031427434.55
76Lymphocyte count | Blood countUKBB0000041134.51
77eosinophil (absolute count, minimum, inv-norm transformed)GCST9047529434.33
78Eosinophill count | Blood countUKBB0000020634.19
79Dermatitis and eczemaFING0000040233.86
80Disorders of orbitFING0000044933.82
81Autoimmune diseases excluding thyroid diseasesFING0000013233.80
82eosinophil (absolute count, maximum, inv-norm transformed)GCST9047528833.71
83PsoriasisFING0000122233.64
84eosinophil (fraction, maximum, inv-norm transformed)GCST9047529733.18
85Lymphocyte countGCST00462733.04
86Pulmonary fibrosisGCST9001868832.71
87Asthma/COPD (KELA code 203)FING0000012132.70
88lymphocyte (fraction, mean, inv-norm transformed)GCST9047543532.51
89Eosinophill percentage (UKB data field 30210)GCST9046806932.46
90Autoimmune diseasesFING0000013132.33
91Eosinophil countGCST00460632.31
92CWC15 levelsGCST9046892032.20
93Neutrophil percentage of granulocytesGCST00462332.03
94Asthma (childhood onset)GCST00780032.01
95HypothyroidismGCST9020416731.94
96HypothyroidismGCST9046813831.87
97AsthmaGCST9046811231.87
98eosinophil (fraction, minimum, inv-norm transformed)GCST9047530331.65
99Sum eosinophil basophil countsGCST00462431.41
100Non-cancer illness code, self-reported - hypothyroidism/myxoedema | Medical conditionsUKBB0000051831.24
101Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Hayfever, allergic rhinitis or eczema | Medical conditionsUKBB0000010031.00
102CD8 on Effector Memory CD8+ T cellGCST9000205630.98
103Thyroid peroxidase antibody levels in pregnancyGCST9043520130.92
104Personal history of allergy to drugs, medicaments and biologocal substances | Persons with potential health hazards related to family and personal history and certain conditions influencing health statusUKBB0000064130.91
105Asthma-related acute respiratory infectionsFING0000011730.56
106Eosinophil percentage of granulocytesGCST00461730.55
107GZMB/IL15 ratioGCST9031501530.52
108Other and unspecified tonsillitisFING0000095430.28
109Hypothyroidism | endocrine/metabolicUKBB0000033530.21
110SNRPB2 levelsGCST9047069730.14
111Psoriasis vulgarisFING0000122430.14
112Other hypothyroidism | Disorders of thyroid glandUKBB0000061130.05
113Eosinophill percentage | Blood countUKBB0000020729.93
114Atopic dermatitisGCST9002716129.85
115Rheumatoid arthritisGCST9013222429.79
116ARHGAP30 levelsGCST9046835429.79
117ICD10 N87: Dysplasia of cervix uteriGCST9045421829.78
118KDM3A levelsGCST9046967129.62
119TNFRSF17 levelsGCST9047090829.50
120Ulcerative rectosigmoiditisFING0000139429.39
121eosinophil (fraction, mean, inv-norm transformed)GCST9047530029.34
122Rash and other nonspecific skin eruption (PheCode 687.1)GCST9047616729.27
123APRT levelsGCST9046834529.19
124AsthmaGCST01004229.07
125Eosinophil percentage of white cellsGCST00460029.00
126Hypothyroidism NOS | endocrine/metabolicUKBB0000033628.98
127Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - None of the above | Medical conditionsUKBB0000010128.88
128Colitis, primary sclerosing, strict definitionFING0000031328.86
129Other diseases of upper respiratory tractFING0000101228.79
130Treatment/medication code - levothyroxine sodium | MedicationsUKBB0000084928.71
131Prescriptions - levothyroxine | thyroid hormoneUKBB0000068728.62
132Prescriptions - thyroid hormone | hormoneUKBB0000070528.62
133CRTAM/GZMA ratioGCST9031427528.51
134Lymphocyte percentage of white cellsGCST9000238928.32
135CD5 levelsGCST9046864128.23
136CCL17/PDGFB ratioGCST9031368828.19
137Eosinophil percentage of white cellsGCST9000238228.19
138Chronic lymphocytic leukemiaGCST9062473828.07
139HSIL lesion of the cervix uteriFING0000062428.02
140Lymphocyte percentage (UKB data field 30180)GCST9046808328.02
141Asthma (only as main-diagnosis) (more control exclusions)FING0000011427.97
142Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor - Asthma | Medical conditionsUKBB0000009827.94
143Graves disease, strict definitionFING0000059227.89
144First line medication for Crohn's diseaseFING0000054427.79
145Neutrophils and lymphocytes in blood (confirmatory factor analysis Factor 35)GCST9030936927.76
146CD48/FCRL6 ratioGCST9031384027.74
147CRTAM levelsGCST9046887127.64
148Rosacea (PheCode 695.3)GCST9047617827.55
149Respiratory disease (confirmatory factor analysis Factor 11)GCST9030934527.43
150Chronic lower respiratory diseasesFING0000029027.37
151Treatment or medication use - levothyroxine sodium (UKB data field 20003_1141191044)GCST9004253527.36
152Coeliac diseaseGCST9046812027.25
153CRTAM/TNFRSF9 ratioGCST9031428027.23
154Seronegative rheumatoid arthritisFING0000129626.91
155LTA4H levelsGCST9046981226.83
156CRTAM/LY9 ratioGCST9031427826.82
157Hypothyroidism NOS (PheCode 244.4)GCST9047565326.78
158Noninfective enteritis and colitisFING0000088126.73
159Type 1 diabetesGCST9001402326.72
160lymphocyte (fraction, minimum, inv-norm transformed)GCST9047543826.68
161IL18 levelsGCST9042841126.66
162Lymphocyte percentage | Blood countUKBB0000041226.50
163Prescriptions - tramadol | opioid analgesic,selective serotonin re-uptake inhibitor,norepinephrine re-uptake inhibitorUKBB0000070626.47
164Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitorUKBB0000069426.47
165CD160 levelsGCST9046859926.44
166Chronic dermatitis due to solar radiation (PheCode 938.2)GCST9047628826.40
167Thyroid problemsGCST9047527626.39
168MZB1 levelsGCST9046998726.35
169Eosinophil countGCST9000229826.35
170Principal component-derived dietary pattern 26GCST9013303126.35
171SarcoidosisGCST9050348326.25
172Childhood asthma (age<16) (more control exclusions)FING0000027026.23
173PALM2 levelsGCST9047015226.19
174Eosinophil countGCST9000238126.16
175CRTAM/ICAM3 ratioGCST9031427626.13
176SKAP1 levelsGCST9047064526.07
177Eosinophill count (UKB data field 30150)GCST9046806825.95
178IL15/IL18BP ratioGCST9031514825.91
179S100A11/S100A12 ratioGCST9031579825.88
180Cerebrospinal fluid methylmalonate (MMA) levelsGCST9031824325.79
181mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544425.78
182GZMA/TNFRSF8 ratioGCST9031501425.75
183IL2RB levelsGCST9046958625.68
184IL15/NCR1 ratioGCST9031515025.67
185Disorders of the thyroid glandFING0000046325.67
186Takes medication for Thyroid problems?GCST9047527725.60
187Asthma (adult onset)GCST00779925.56
188GZMH/KLRD1 ratioGCST9031501625.43
189GZMA/TNFRSF4 ratioGCST9031501325.33
190Volume of right central nucleusGCST9047491625.32
191Hypothyroidism (PheCode 244)GCST9047564725.30
192SMNDC1 levelsGCST9047068125.27
193Neurofibromatosis, type 2FING0000086725.22
194GZMB levelsGCST9046942425.15
195SMPD3 levelsGCST9047068525.13
196Allergy/adverse effect of penicillin | injuries & poisoningsUKBB0000002825.12
197CD244/FCRL6 ratioGCST9031376525.11
198Systemic lupus erythematosusGCST9001186625.05
199DNAJC21 levelsGCST9046901624.99
200LAT/LYN ratioGCST9031528324.82
201Sporadic miscarriageGCST01188824.66
202Non-cancer illness code, self-reported - asthma | Medical conditionsUKBB0000050624.65
203Benign leiomyoma with endometriosis (controls excluding all cancers)FING0000014524.58
204HypothyroidismGCST9031932024.53
205Diseases of hair and hair follicles (PheCode 704)GCST9047620924.23
206Asthma and allergyFING0000011524.20
207Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)FING0000075624.18
208Disorders of sclera, cornea, iris and ciliary bodyFING0000045824.09
209Thyroid peroxidase antibody positivity with euthyroid in pregnancyGCST9043520324.04
210Hypothyroidism, strict autoimmuneFING0000065623.89
211GZMA/LTA ratioGCST9031501223.83
212Inflammatory bowel disease, strict (require KELA)FING0000067523.81
213MAPRE3 levelsGCST9046985923.70
214CD6 levelsGCST9046864423.68
215Primary biliary cholangitis (PBC)FING0000121123.66
216PsoriasisGCST9046814723.66
217COPD/asthma/ILD related infectionsFING0000035323.64
218CD7 levelsGCST9046864923.46
219Poisoning by antibiotics | injuries & poisoningsUKBB0000065323.31
220IridocyclitisFING0000069622.92
221Asthma (more control exclusions)FING0000011322.88
222Blood cell traits latent factor 3 (white cell)GCST9055924522.84
223VEGFB levelsGCST9047103522.81
224Basal cell carcinoma (MTAG)GCST9013741122.79
225Type1 diabetes, definitions combined, early onsetFING0000138422.77
226Other (seronegative) rheumatoid arthritis, wideFING0000091722.69
227Crohn disease (strict definition, require KELA, min 2 HDR)FING0000036622.69
228Allergic disease (asthma, hay fever or eczema)GCST00503822.67
229Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050239622.63
230AsthmaGCST9001432522.59
231Mosaic chromosomal alteration of the X chromosomeGCST9016528722.58
232PolyarthropathiesFING0000118022.55
233DTI autoptx MD cgc l tractGCST9038522422.40
234Coeliac diseaseFING0000031222.32
235Rheumatoid arthritis (PheCode 714.1)GCST9047623022.23
236Acute pancreatitisFING0000002722.15
237PDCD1 levelsGCST9047018122.10
238Seborrhoeic dermatitisFING0000128222.01
239Nasal polyps | respiratoryUKBB0000049421.96
240Seborrheic dermatitis (PheCode 690.1)GCST9047617121.95
241PPM1B levelsGCST9047029621.90
242Lymphoid leukemia, chronic (PheCode 204.12)GCST9047561321.87
243Erythematosquamous dermatosis (PheCode 690)GCST9047617021.72
244CD79B/TNFRSF4 ratioGCST9031390321.71
245Alcohol-induced chronic pancreatitisFING0000005521.66
246DNA methylation-estimated granulocyte proportionsGCST9001428721.66
247EDAR/EGF ratioGCST9031457321.63
248Cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) with severe ocular complicationsGCST9009311321.61
249Primary biliary cholangitisGCST9006144021.53
250Thyrotoxicosis with diffuse goitreFING0000136121.46
251ThyrotoxicosisFING0000136021.36
252FASLG levelsGCST9046919121.30
253GBP1 levelsGCST9046931121.26
254FCRL6/GZMA ratioGCST9031480621.24
255Blood cell traits latent factor 9 (white cell)GCST9055925121.14
256BMP7 levelsGCST9008815721.04
257PDCD1/TNFRSF8 ratioGCST9031561021.01
258HSPB1 levelsGCST9017931721.00
259Allergic asthma (mode)FING0000006620.99
260Ulcerative colitisGCST9001871320.94
261Plasma ascorbic acid 2-sulfate levels in chronic kidney diseaseGCST9026483220.88
262CRTAM/KLRD1 ratioGCST9031427720.80
263Smoking status (weighted GWA)GCST9026730320.68
264TNFRSF19 levelsGCST9008894720.68
265LHPP levelsGCST9046976820.52
266HSIL lesion of the cervix uteri, vagina or vulvaFING0000062520.20
267BLNK levelsGCST9046844820.15
268NBN levelsGCST9047000220.06
269Non-cancer illness code, self-reported - hayfever/allergic rhinitis | Medical conditionsUKBB0000051320.04
270KLRB1 levelsGCST9046970919.98
271Overweight, obesity and other hyperalimentation | endocrine/metabolicUKBB0000062219.97
272Nasal polyp | Other diseases of upper respiratory tractUKBB0000049319.96
273Type 1 diabetes, definitions combinedFING0000138019.93
274T1 FreeSurfer aseg MaskVol-to-eTIVGCST9038419219.88
275UGDH levelsGCST9047100619.76
276Non-cancer illness code, self-reported - eczema/dermatitis | Medical conditionsUKBB0000050919.64
277Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066852419.63
278Omega-3 fatty acids to total fatty acids percentageGCST9050246019.60
279Rheumatoid arthritisGCST9001869019.58
280ACYP1 levelsGCST9046821419.58
281Graves' disease (PheCode 242.1)GCST9047564419.57
282PCBD1 levelsGCST9047016619.51
283Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)FING0000076419.41
284Idiopathic pulmonary fibrosisFING0000065919.38
285CRTAM/PDCD1 ratioGCST9031427919.37
286Inflammatory bowel disease and other gasteroenteritis and colitis (PheCode 555)GCST9047606519.33
287PollinosisGCST9001868319.33
288Dissociative [conversion] disordersFING0000046819.11
289Wheeze or whistling in the chest in last year (UKB data field 2316)GCST9004361418.93
290IL2RA/NCR1 ratioGCST9031516118.91
291Other/unspecified rheumatoid arthritisFING0000112618.73
292BOLA2 or BOLA2B levelsGCST9046846018.69
293Acute upper respiratory infectionsFING0000003418.64
294Eosinophil countGCST9000229918.64
295KLF4 levelsGCST9046969418.60
296Inflammatory bowel diseaseGCST9043218218.58
297TALDO1 levelsGCST9047080218.57
298CD48/SLAMF7 ratioGCST9031384218.56
299Wheeze or whistling in the chest in last year | BreathingUKBB0000091218.55
300AsthmaGCST9047525918.53
301Avoided activities or situations because of previous stressful experience in past month | Traumatic eventsUKBB0000008318.49
302FCRL5/LY96 ratioGCST9031480318.38
303FCRL6/KLRD1 ratioGCST9031480718.34
304T1 FreeSurfer DK rh supramarginal volumeGCST9038578718.33
305CLC levelsGCST9046876218.29
306CXCL16/NOTCH1 ratioGCST9031433918.26
307MICB_MICA/TEK ratioGCST9031544618.26
308OSMR levelsGCST9047013218.21
309Ulcerative colitisGCST00413318.20
310Asthma with exacerbation (PheCode 495.2)GCST9047602518.17
311Blood cell traits latent factor 17 (white cell)GCST9055925918.14
312CD20 on IgD- CD27- B cellGCST9000175418.13
313Lymphocyte percentage of white cellsGCST00463218.11
314IFI30 levelsGCST9046950918.07
315Operation code - tonsillectomy +/- adenoids | OperationsUKBB0000056718.03
316Skin cancerGCST9047557517.90
317Ceramide (d18:2/22:0) levelsGCST9002468217.87
318Hair colour (natural, before greying): Dark brown (UKB data field 1747_4)GCST9004183917.87
319Omega-3 fatty acids to total fatty acids percentageGCST9050244817.85
320Eosinophil count varianceGCST9056568917.81
321SH2D1A levelsGCST9047061717.76
322Graves' diseaseGCST9001862717.74
323DTI TBSS MD Superior corona radiata LGCST9038459717.73
324Other demyelinating diseases of the central nervous systemFING0000099517.71
325Eosinophil countGCST9001873317.70
326PAG1 levelsGCST9047014717.59
327C5 levelsGCST9046850017.55
328AHNAK levelsGCST9046826117.51
329Rheumatoid arthritis (rheumatoid factor and/or anti-cyclic citrullinated peptide seropositive)GCST9013222717.49
330Basal cell carcinoma (PheCode 172.21)GCST9047558217.48
331Nasal polyps (PheCode 471)GCST9047601917.44
3325-oxoproline levelsGCST9024343717.42
333Autoimmune hyperthyroidismFING0000013417.39
334mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047544817.31
335ICD10 O60: Preterm labor and deliveryGCST9045424217.26
336Incidence of bisecting GlcNAc in all fucosylated disialylated structures (GP57)GCST9066873517.25
337CXCL11/DKK1 ratioGCST9031433417.25
338Rheumatoid arthritisGCST00067917.23
339Treatment/medication code - ibuprofen | MedicationsUKBB0000084717.12
340IPCEF1/SERPINE1 ratioGCST9031518417.05
341Medication use (drugs affecting bone structure and mineralization)GCST9001877317.05
342CD300A levelsGCST9046861917.03
343DNA methylation PhenoAge accelerationGCST9001429216.97
344X-21285 levelsGCST9020057616.82
345DCTN1/TRIAP1 ratioGCST9031443416.79
346KIR2DL3 levelsGCST9046968516.77
347DTI TBSS MD Posterior limb of internal capsule LGCST9038459116.76
348Hair colour (natural, before greying) - Dark brown | Sun exposureUKBB0000029716.75
349Obesity | endocrine/metabolicUKBB0000054416.74
350SIT1 levelsGCST9047064416.73
351Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classifiedFING0000043216.67
352PDCD1/TNFRSF4 ratioGCST9031560916.64
353Non-cancer illness code, self-reported - hiatus hernia | Medical conditionsUKBB0000051516.54
354DKK1/IPCEF1 ratioGCST9031447116.54
355CD101 levelsGCST9046859616.52
356CD27/NBL1 ratioGCST9031377416.50
357neutrophil (fraction, minimum, inv-norm transformed)GCST9047554116.50
358Other non-epithelial cancer of skin (PheCode 172.2)GCST9047558016.48
359Percentage of fucosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP80)GCST9066875816.47
360Obesity | Obesity and other hyperalimentationUKBB0000054516.47
361T1 FreeSurfer BA lh V2 exvivo thicknessGCST9038552916.42
362Other acute lower respiratory infectionsFING0000092116.42
363Eosinophil countGCST9002598716.38
364DTI autoptx L1 cst l tractGCST9038514716.33
365ICD10 N84: Polyp of female genital tractGCST9045421616.32
366ZNF830 levelsGCST9047110216.30
367IL10 levelsGCST9046954616.27
368Interpolated Year when non-cancer illness first diagnosed | Medical conditionsUKBB0000037116.22
369LCN2/PGLYRP1 ratioGCST9031530616.16
370KIR3DL1 levelsGCST9046968716.03
371Ulcerative colitis (strict definition, require KELA, min 2 HDR)FING0000138816.01
372CCL17/CD69 ratioGCST9031368415.99
373Ceramide (d18:2/22:0) levelsGCST9002405415.72
374HyperthyroidismGCST9031931915.72
375Mean reticulocyte volumeGCST9002597515.63
376Fluid intelligence score decline (difference score)GCST9056586215.59
377WARS levelsGCST9047106615.59
378SELPLG levelsGCST9047056815.51
379HayfeverGCST9046813115.48
380BCL2 levelsGCST9046843315.46
381Solitary pulmonary nodule (PheCode 514.2)GCST9047604415.46
382Percentage of fucosylation of monogalactosylated structures in total neutral plasma glycans (GP74)GCST9066851815.45
383PTPRC levelsGCST9047038015.43
384Atopic/contact dermatitis due to other or unspecified (PheCode 939)GCST9047628915.40
385T1 FreeSurfer DKT rh supramarginal volumeGCST9038437715.35
386Treatment/medication code - ventolin 100micrograms inhaler | MedicationsUKBB0000086015.32
387KLRF1 levelsGCST9046971215.24
388Primary biliary cholangitisGCST00312915.23
389IL5RA/TNFRSF13B ratioGCST9031516415.19
390CD40LG/TRAF2 ratioGCST9031382815.11
391T1 FreeSurfer DK lh lingual thicknessGCST9038563415.10
392PAXX levelsGCST9047016115.08
393Melanomas of skin (PheCode 172.11)GCST9047557815.06
394CCL19 levelsGCST9046857115.06
395CD27/TGFBR2 ratioGCST9031377615.05
396CXCL16 levelsGCST9024052415.04
397Blood cell traits latent factor 12 (red cell)GCST9055925414.98
398GRAP2/SRC ratioGCST9031498914.93
399Squamous cell carcinoma (PheCode 172.22)GCST9047558314.91
400SH2B3/TBL1X ratioGCST9031584114.91
401PM: initial answer - Orange circle| Prospective memoryUKBB0000065214.90
402CRTAP levelsGCST9046887214.85
403Orotidine levelsGCST9020068114.84
404CD5/IL16 ratioGCST9031386114.71
405EGFL7 levelsGCST9046908314.71
406Cervical cancerGCST9001181614.69
407Percentage of monosialylation of core-fucosylated monogalactosylated structures without bisecting GlcNAc (GP41)GCST9066848514.69
408MAVS/TBL1X ratioGCST9031539914.69
409EDAR/TACC3 ratioGCST9031458914.68
410Skin color (cheek, ITA value)GCST9050278014.67
411Basophil countGCST9000229314.61
412Multiple myelomaGCST9062474714.50
413COX5B/GFER ratioGCST9031420014.46
414IL15/KLRD1 ratioGCST9031514914.45
415PDCD5 levelsGCST9047018214.45
416Mean corpuscular hemoglobin concentrationGCST9001874514.44
417Bipolar disorderGCST00372414.44
418neutrophil (fraction, mean, inv-norm transformed)GCST9047553814.41
419PBLD levelsGCST9047016314.39
420Hypothyroidism, drug reimbursementFING0000065514.34
421Age hay fever, rhinitis or eczema diagnosed | Medical conditionsUKBB0000001514.28
422ARHGAP25/RNF41 ratioGCST9031334514.27
423Ulcerative colitis, NASFING0000139014.27
424Skin cancerGCST9047518914.24
425Treatment speciality of consultant (recoded) - Trauma & orthopaedics | Summary AdministrationUKBB0000083714.24
426Carboplatin drug response (IC50)GCST9001178314.23
427Omega-3 fatty acids to total fatty acids percentageGCST9050208714.21
428Sicca syndrome [Sjögren]FING0000130414.19
429PIKFYVE levelsGCST9047023514.16
430Biological Sibling: AsthmaGCST9047637214.14
431EndometriosisGCST9001861914.10
432Lichen simplex chronicus and prurigoFING0000072514.07
433Early-onset myasthenia gravisGCST9009346514.06
434Nonspecific chest pain | circulatory systemUKBB0000052714.00
435Lung adenocarcinomaGCST00474414.00
436DEFA1_DEFA1B/PTGDS ratioGCST9031445513.99
437Juvenile rheumatoid arthirtisFING0000070613.97
438Infective dermatitisFING0000067313.95
439GZMA levelsGCST9046942313.94
440CCR2 on CD14+ CD16- monocyteGCST9000200413.90
441EczemaGCST9046812613.87
442CD83/IL12A_IL12B ratioGCST9031390513.82
443T1 FreeSurfer a2009s lh S postcentral areaGCST9038473413.72
444Lymphoid neoplasms (P-cell phenocluster)GCST9062473713.72
445TIGIT levelsGCST9047086513.68
446Asthma-related pneumoniaFING0000011913.67
447SarcoidosisFING0000127513.66
448Hair colour (natural, before greying): Red (UKB data field 1747_2)GCST9004183713.64
449Other specified disorders of external earFING0000110413.62
450Melanomas of skin, dx or hx (PheCode 172.1)GCST9047557713.61
451MelanomaGCST9001180913.58
452TRAF2/WWP2 ratioGCST9031594313.57
453INSR levelsGCST9046962313.52
454CDH17/PECAM1 ratioGCST9031394213.48
455Scar conditions and fibrosis of skin (PheCode 701.2)GCST9047619813.46
456ROR1/THBD ratioGCST9031578613.45
457Eosinophil percentage of white cells varianceGCST9056569013.43
458CSNK1D levelsGCST9046888813.42
459Crohn's diseaseGCST00413213.37
460Left-hemisphere control network to amygdala white-matter structural connectivityGCST9030275713.35
461Multiple myeloma or monoclonal gammopathy of undetermined significanceGCST9062474613.35
462FCRL5/ICAM3 ratioGCST9031480213.31
463Mean reticulocyte volume | Blood countUKBB0000045113.31
464HMBS/PKLR ratioGCST9031506313.30
465CD27/DLL1 ratioGCST9031377113.29
466DTI autoptx MD str r tractGCST9038524413.27
467PLXNA4/SRPK2 ratioGCST9031568813.26
468ChalazionFING0000026713.24
469MICB or MICA levelsGCST9046990513.17
470CXCL9 levelsGCST9027478413.17
471EDAR/F2R ratioGCST9031457713.17
472Crohn's disease NASFING0000036713.17
473KLRK1 levelsGCST9046971313.15
474Principal component-derived dietary pattern 9GCST9013301413.11
475aparc-Desikan rh volume insulaGCST9000283413.08
476IL5RA levelsGCST9046960013.07
477Aplastic anemia (PheCode 284)GCST9047578313.07
478CD74/NPDC1 ratioGCST9031389513.06
479IGLC2 levelsGCST9046953613.03
480Actinic keratosis (PheCode 702.1)GCST9047620413.02
4813-methyl-2-oxobutyrate levelsGCST9019967713.02
482Blood cell traits latent factor 20 (red cell)GCST9055926213.02
483Basal cell carcinomaGCST9001341013.00
484FUT8/RSPO1 ratioGCST9031489112.99
485Other non-epithelial cancer of skin | neoplasmsUKBB0000061512.97
486CDA levelsGCST9046866012.95
487CD27/NECTIN4 ratioGCST9031377512.93
488RILP levelsGCST9047047112.93
489KCTD5 levelsGCST9046967012.89
490TBCA levelsGCST9047081212.88
491APBB1IP/POLR2F ratioGCST9031330012.87
492FUT8/TNFSF14 ratioGCST9031489512.83
493CLPS/PLA2G1B ratioGCST9031414012.76
494MSRA/PRDX5 ratioGCST9031549712.75
495Chronic pancreatitisGCST9001860112.68
496JCHAIN levelsGCST9046966112.66
497Regional enteritis (PheCode 555.1)GCST9047606612.65
498Vanillactate levelsGCST9019997812.64
499CD20 on IgD- CD38- B cellGCST9000175512.62
500Non-albumin protein levelsUKBB0000050312.61
501LCN2/S100A12 ratioGCST9031530912.61
502AKT1S1/FHIT ratioGCST9031322812.60
503Hair colour (natural, before greying) - Black | Sun exposureUKBB0000029512.60
504ATP5IF1/LYN ratioGCST9031338912.59
505Mean corpuscular hemoglobin concentrationGCST9000232912.57
506TSC1 levelsGCST9047097212.57
507Prescriptions - antispasmodicUKBB0000066612.56
508Symptoms involving digestive system (PheCode 561)GCST9047606912.56
509aseg lh volume HippocampusGCST9000262412.55
510LSP1 levelsGCST9046981112.49
511TP53I3 levelsGCST9047093712.47
512Rheumatoid arthritis | musculoskeletalUKBB0000075712.46
513MZB1/TNFRSF13B ratioGCST9031550912.39
514CNTNAP4 levelsGCST9046880912.36
515LAIR2 levelsGCST9046972912.36
516Rheumatoid arthritis and other inflammatory polyarthropathies | musculoskeletalUKBB0000075812.36
517Never eat sugar vs no sugar restrictions (UKB data field 6144)GCST9013293412.32
518Mean sphered cell volume (UKB data field 30270)GCST9046808912.30
519CD244 levelsGCST9046861112.28
520Human herpes virus 7 U14 antibody levelsGCST9000690912.27
521Basophil countGCST9002599712.25
522FOXO3 levelsGCST9046926612.25
523IBD (strict) with PSCFING0000065712.24
524Omega-3 fatty acids to Omega-6 fatty acids ratioGCST9050207412.23
525Neoplasm of uncertain behavior of skin (PheCode 173)GCST9047558512.20
526EDAR/ERBIN ratioGCST9031457512.17
527TNFSF12 levelsGCST9027484612.17
528Peripheral or central vertigo (PheCode 386.2)GCST9047590712.16
529ALB/Globulin ratioUKBB0000002012.14
530White blood cell countGCST9002598512.14
531CA1/HMBS ratioGCST9031357312.13
532Diseases of white blood cells (PheCode 288)GCST9047581212.13
533Lung cancerGCST9001865512.12
534DTI TBSS L3 Genu of corpus callosumGCST9038452612.11
535BOC levelsGCST9046845812.08
536CDH17/PTPRM ratioGCST9031394312.08
537CA3/HMBS ratioGCST9031358412.07
538GLO1 levelsGCST9046935812.04
539Ulcerative colitisGCST9044679512.04
540STX6 levelsGCST9047077412.04
541CD27/TNFRSF9 ratioGCST9031377812.03
542Monoclonal gammopathy of undetermined significanceGCST9062474512.03
543AHSP/HMBS ratioGCST9031321711.98
544PEAR1/PECAM1 ratioGCST9031564111.97
545neutrophil (fraction, maximum, inv-norm transformed)GCST9047553511.97
546Lung cancerGCST00474811.92
547Number of attempts | Prospective memoryUKBB0000053111.90
548HippSubfield lh volume CA4-bodyGCST9000268311.88
549Neutrophil percentage of white cellsGCST9000239911.87
550Chromatiales abundance in stoolGCST9003231811.83
551S100A12 levelsGCST9047051311.81
552Other malignant neoplasms of skin | Melanoma and other malignant neoplasms of skinUKBB0000061311.81
553Preterm labour and deliveryFING0000120911.78
554Omega-3 fatty acid levelsGCST9050242211.74
555LAT/PLXNA4 ratioGCST9031528611.74
556Attendance/disability/mobility allowance - None of the above | Other sociodemographic factorsUKBB0000005911.73
557Ever SmokerFING0000052211.71
558IL32 levelsGCST9046959111.70
559ENO3 levelsGCST9046911111.68
560HippSubfield lh volume GC-ML-DG-headGCST9000267911.62
561SRP14 levelsGCST9047074211.57
562Belief that own life is meaningful | Happiness and subjective well-beingUKBB0000009011.56
563APRT/CD63 ratioGCST9031333411.55
564Neutrophill percentage (UKB data field 30200)GCST9046809311.50
565ICD10 N97.8: Female infertility of other originGCST9045422511.50
566Type 1 diabetesGCST9043206611.49
567AsthmaGCST9047602411.43
568AsthmaGCST00686211.43
569CD27/CD79B ratioGCST9031377011.42
570Mouth/teeth dental problems - None of the above | MouthUKBB0000048911.41
571Rhodanobacter abundance in stoolGCST9003253611.39
572NRSN1 levelsGCST9024206211.38
573aparc-a2009s rh thickness G-temporal-middleGCST9000371411.36
574CD27 levelsGCST9046861511.34
575Sjögren's syndromeGCST9001870011.34
576CDH17/SPINT1 ratioGCST9031394411.32
577HSPA1A levelsGCST9046948711.29
578IL1RL1 levelsGCST9046957411.28
579CAPG levelsGCST9046853711.27
580mean corpuscular hemoglobin (MCH, minimum, inv-norm transformed)GCST9047545011.26
581Trouble falling asleep when you first go to bedGCST9047638511.23
582Mean sphered cell volume | Blood countUKBB0000045211.22
583SPINK2 levelsGCST9047072211.21
584GP6/HPCAL1 ratioGCST9031496311.18
585Ulcerative colitis (PheCode 555.2)GCST9004415511.18
586Current SmokerFING0000037111.16
587MAVS/MED18 ratioGCST9031538911.16
588Systemic connective tissue disordersFING0000135011.16
589LBR/POLR2F ratioGCST9031529711.11
590RHOC/TBCB ratioGCST9031577411.07
591ENO2/RWDD1 ratioGCST9031466711.03
592mean corpuscular volume (MCV, minimum, inv-norm transformed)GCST9047547411.01
593FCRL5 levelsGCST9046920811.00
594PM: initial answer - Blue square | Prospective memoryUKBB0000065110.98
595PFKM levelsGCST9061880210.96
596mean corpuscular hemoglobin (MCH, maximum, inv-norm transformed)GCST9047544210.94
597mean corpuscular volume (MCV, maximum, inv-norm transformed)GCST9047546610.92
598CLEC4D/CLEC6A ratioGCST9031410910.90
599HippSubfield lh volume Whole-hippocampusGCST9000268910.88
600Skin cancer | neoplasmsUKBB0000077210.84
601mean corpuscular volume (MCV, mean, inv-norm transformed)GCST9047547010.83
602Crohn's disease of small intestineFING0000036910.82
603Urine N-acetylglutamate levels in chronic kidney diseaseGCST9026556910.80
604KIR2DL2 levelsGCST9046968410.76
605HLA-A levelsGCST9046945710.75
606Other localized connective tissue disordersFING0000106610.75
607DTI TBSS L3 Superior corona radiata LGCST9038454910.74
608aparc-a2009s rh thickness G-oc-temp-med-LingualGCST9000369810.72
609DNAJA2/PLXNA4 ratioGCST9031450410.72
610GRAP2/MAP4K5 ratioGCST9031498210.68
611DTI TBSS MD Genu of corpus callosumGCST9038457410.67
612BTN3A2 levelsGCST9046848110.66
613Celiac disease (PheCode 557.1)GCST9004415810.64
614HippSubfield lh volume GC-ML-DG-bodyGCST9000268110.64
615Never eat eggs, dairy, wheat, sugar - Sugar or foods/drinks containing sugar | DietUKBB0000050110.64
616Acute renal failureFING0000003010.63
617CLEC1B/DAB2 ratioGCST9031408610.62
618Completion of the aide-memoireGCST9001279310.53
619TNF/TNFRSF1B ratioGCST9031594210.52
620Types of physical activity in last 4 weeks - None of the above | Physical activityUKBB0000087210.48
621CC2D1A/STAMBP ratioGCST9031366410.48
622Crohn's diseaseGCST9044679310.47
623Tryptophan betaine levelsGCST9019981910.47
624mean corpuscular hemoglobin (MCH, mean, inv-norm transformed)GCST9047544610.45
625Right-hemisphere dorsal attention network to amygdala white-matter structural connectivityGCST9030281110.42
626REST UKBBICA NODEamps25 0006GCST9038548910.40
627Basophil countGCST9001872610.39
628Degenerative skin conditions and other dermatoses (PheCode 702)GCST9047620210.38
629GFRA2/IL12A_IL12B ratioGCST9031492510.38
630TTN levelsGCST9047098410.35
631CD300E/EFNA4 ratioGCST9031379710.33
632Mean reticulocyte volumeGCST9000239610.32
633Hair colour (natural, before greying): Light brown (UKB data field 1747_3)GCST9004183810.31
634Epstein-Barr virus ZEBRA antibody levelsGCST9000690110.24
635FYN levelsGCST9024320010.22
636ADAM15 levelsGCST9046821710.13
637X-16087 levelsGCST9020053710.13
638DTI autoptx L1 cst r tractGCST9038514810.13
639Rheumatoid arthritis and other inflammatory (PheCode 714)GCST9047622810.12
640Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST9066873910.11
641LBR/LGALS8 ratioGCST9031529410.11
642Mean reticulocyte volume (UKB data field 30260)GCST9046808810.10
643Ratio of bis-allylic bonds to double bonds in lipidsGCST9013274410.09
644Hepatic cancerGCST9001863810.09
645HippSubfield lh volume Hippocampal-tailGCST9000266810.08
646Educational attainmentGCST00259810.08
647Neutrophill percentage | Blood countUKBB0000049810.05
648ConjunctivitisFING0000034610.04
649Mean corpuscular hemoglobinGCST00463010.03
650DNAJB2 levelsGCST9046901310.02
651Never eat sugar vs no eggs, dairy, wheat or sugar restrictions (UKB data field 6144)GCST9013293310.01
652T1 FreeSurfer aseg Right-PallidumGCST9038416410.01
653PSAPL1 levelsGCST9024235410.00
654Psoriatic arthropathiesFING000012259.97
655RCC1 levelsGCST904704439.93
656Erythematous conditions (PheCode 695)GCST904761779.90
657Secondary hypothyroidism (PheCode 244.1)GCST904756499.88
658TNFRSF9 levelsGCST904709169.88
659EDAR/LAT2 ratioGCST903145829.85
660EPHB6/TNFRSF9 ratioGCST903146829.84
661Acute bronchitisFING000000219.83
662Mean spheric corpuscular volumeGCST900023979.82
663DTYMK levelsGCST904690499.81
664Prospective memory result | Prospective memoryUKBB000007139.80
665CD20 on IgD- CD24- B cellGCST900017539.78
666Polymyalgia rheumaticaFING000011889.78
667CD48 levelsGCST904686359.77
668CLIC5 levelsGCST904217409.77
669MAN2B2 levelsGCST904698449.76
670Pilonidal cystFING000011679.76
671Hair colour (natural, before greying): Black (UKB data field 1747_5)GCST900418409.74
672Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)FING000007729.71
673aseg lh volume Accumbens-areaGCST900026269.70
674Nasal polypsGCST904681439.70
675Principal component-derived dietary pattern 16GCST901330219.65
676VSTM2B levelsGCST904710569.63
677Diseases of the digestive systemFING000004299.62
678NPDC1/PTGDS ratioGCST903155499.60
679CD6/EZR ratioGCST903138909.59
680Other alveolar and parietoalveolar pneumonopathy (PheCode 504)GCST904760339.57
681RIDA levelsGCST904704699.56
682Triacylglycerol_56:6_[M+NH4]1+ levelsGCST900605539.56
683F-caffeinated/sweet liking (derived food-liking factor)GCST900947209.56
684DBNL/EDAR ratioGCST903144169.49
685SNX2 levelsGCST904707019.47
686Hernia abdominopelvic cavityGCST900860879.46
687Lumbar disc prolapseFING000007359.44
688Ulcerative colitisGCST904753229.43
689ATOX1/SNAP29 ratioGCST903133749.41
690CD72 levelsGCST904686469.41
691Lichen sclerosus et atrophicusFING000007239.41
692KLRD1/LY9 ratioGCST903152619.40
693N2-acetyl,N6,N6-dimethyllysine levelsGCST902006979.40
694CD58/MEGF10 ratioGCST903138539.40
695Pain in throat and chest | Symptoms and signs involving the circulatory and respiratory systemsUKBB000006259.40
696ARHGEF12/DECR1 ratioGCST903133499.40
697CD69/EDAR ratioGCST903138759.38
698CXCL16 levelsGCST900120599.38
699Oxalate (ethanedioate) levelsGCST901996729.36
700Takes medication for Skin condition (ex. Eczema, Psoriasis)?GCST904752759.34
701DTI autoptx L3 slf r tractGCST903852159.28
702Handedness (chirality/laterality) - Left-handed | Early life factorsUKBB000003029.27
703Percentage of fucosylation of monogalactosylated structures (with bisecting GlcNAc) in total neutral plasma glycans (GP82)GCST906685269.27
704TOP2B levelsGCST904709349.25
705Endometrial cancerGCST0064649.24
706Vitamin B12 deficiency anaemiaFING000014419.22
707TPSAB1 levelsGCST904709519.20
708Autoimmune hepatitisGCST900185659.18
709SPESP1 levelsGCST904707209.17
710UrticariaFING000014089.17
711Mean corpuscular hemoglobinGCST900023909.17
712Mean corpuscular volumeGCST900023929.17
713Other contact dermatitisFING000009909.16
714ARG1 levelsGCST904683509.16
715Ulcerative colitisGCST904681529.16
716SH3GLB2 levelsGCST904706219.15
717Hair colour (natural, before greying) - Light brown | Sun exposureUKBB000002989.14
718CCL3 levelsGCST904685829.14
719ENO2/PLXNA4 ratioGCST903146659.14
720CEACAM8/PGLYRP1 ratioGCST903140039.12
721Seminoma of testis, excluding all cancers (controls excluding all cancers)FING000012899.08
722DTI TBSS MD Anterior limb of internal capsule LGCST903845899.08
723DNAJB14 levelsGCST904272359.04
724SLAMF8 levelsGCST904706529.03
725Myasthenia gravisGCST904321569.01
726FCRL2/LY9 ratioGCST903147999.01
727DTI TBSS MD Superior longitudinal fasciculus LGCST903846139.00
728Biological Mother: High blood pressureGCST904754908.99
729HBEGF/WWP2 ratioGCST903150388.96
730METAP1D/PLXNA4 ratioGCST903154278.95
731PRG2 levelsGCST904703228.94
732Chronic diseases of tonsils and adenoidsFING000002838.93
733CEP85 levelsGCST904687168.91
734SUMF1 levelsGCST904707838.90
735CD163/ICAM1 ratioGCST903137358.89
736Chronic hepatitis B infectionGCST900185848.87
737EZR levelsGCST904691628.83
738BCL2L15 levelsGCST904684318.82
739Biliverdin levels in chronic kidney diseaseGCST902574958.81
740CCL4 levelsGCST0044338.79
741HBEGF/PLXNA4 ratioGCST903150368.78
742T1 FreeSurfer BA lh BA2 exvivo volumeGCST903855348.75
743Excessive scarringGCST904833688.74
744SLITRK2 levelsGCST904706708.73
745PRG3 levelsGCST904703238.72
746Mean corpuscular volumeGCST0046028.70
747UCMA levelsGCST902432858.70
748Symptoms concerning nutrition, metabolism, and development (PheCode 1002)GCST904755568.70
749Paraproteinemia (PheCode 270.32)GCST904757108.67
750ICAM3/SLAMF7 ratioGCST903151238.67
751MVK/SERPINE1 ratioGCST903155058.65
752Principal component-derived dietary pattern 12GCST901330178.65
753ELOA/POLR2F ratioGCST903146438.62
754Frequency of stair climbing in last 4 weeks | Physical activityUKBB000002668.60
755PIK3IP1/TNFRSF1B ratioGCST903156548.59
756TRAF3 levelsGCST904709578.58
757Methods of admission to hospital (recoded) - Elective admission: Booked | Summary AdministrationUKBB000004618.58
758DTI TBSS L3 Sagittal stratum LGCST903845558.55
759Mean corpuscular haemoglobin (UKB data field 30050)GCST904680848.54
760Peripheral enthesopathies and allied syndromes | musculoskeletalUKBB000006408.54
761Atopic dermatitisGCST900185648.54
762GOPC/IRAK4 ratioGCST903149548.54
763Mean corpuscular volume (UKB data field 30040)GCST904680868.52
764FCRL1/TCL1A ratioGCST903147958.50
765GP1BA/HBEGF ratioGCST903149568.49
766Congenital malformations of ovaries, fallopian tubes and broad ligamentsFING000003378.49
767Doctor diagnosed hayfever or allergic rhinitis | Medical informationUKBB000001928.47
768FOLR2/HAVCR2 ratioGCST903148658.47
769TDP1 levelsGCST904708268.46
770LAYN/PTPRN2 ratioGCST903152908.46
771Actinic keratosisFING000000138.44
772MAP2K1 levelsGCST904698518.42
773DTI TBSS L3 Superior fronto-occipital fasciculus RGCST903845668.41
774T1 FreeSurfer a2009s lh S central thicknessGCST903847868.39
775Other systemic involvement of connective tissue (FG)FING000011168.39
776Childhood sunburn occasions | Sun exposureUKBB000001308.37
777XCL1 levelsGCST904710818.36
778CCL5/LAMA4 ratioGCST903137038.35
779Fluid intelligence score decline (log-difference score)GCST905658528.33
780TNFRSF14/TNFSF14 ratioGCST903159368.33
781LY96 levelsGCST904698238.32
782Dried fruit consumptionGCST901329808.31
783PEBP1 levelsGCST904702058.31
784Destinations on discharge from hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000001678.31
785GSTA4 levelsGCST902412838.30
786IL16 levelsGCST904695578.30
787PXN levelsGCST904703968.30
788B2M levelsGCST904684098.29
789N-acetylmethionine levelsGCST902002898.28
790IL22 levelsGCST904695828.28
791Bread type: Wholemeal/wholegrain vs white and brown (UKB data field 1448)GCST901329688.26
792NMNAT1 levelsGCST904700578.24
793Prescriptions - paracetamol | antipyreticUKBB000006968.23
794Prescriptions - antipyreticUKBB000006658.23
795Triacylglycerol_52:5_[M+NH4]1+ levelsGCST900605068.22
796Type 1 diabetesGCST900187058.21
797Obesity related asthmaFING000008978.19
798TXNDC15 levelsGCST904709908.17
799IDP dMRI TBSS ICVF Medial lemniscus RGCST900043358.17
800DTI TBSS MD Cingulum cingulate gyrus LGCST903846078.17
801Plasma taurocholenate sulfate* levels in chronic kidney diseaseGCST902660408.13
802Omega-3 fatty acids to Omega-6 fatty acids ratioGCST905020688.13
803Parental longevity (combined parental age at death)GCST0067028.10
804Other haemoglobinopathiesFING000010538.08
805Time spent watching television (TV) | Physical activityUKBB000008218.08
806DermatitisFING000004018.07
807CDKN2D/FOXO1 ratioGCST903139858.07
808ERBIN/LYN ratioGCST903146948.04
809Right-hemisphere visual network to right-hemisphere dorsal attention network white-matter structural connectivityGCST903027768.04
810aparc-Desikan lh area fusiformGCST900030798.02
811STIP1 levelsGCST904707648.00
812DTI autoptx L1 slf r tractGCST903851617.99
813IDP T1 FAST ROIs R front operc cortexGCST900025327.99
814Non-cancer illness year/age first occurred | Medical conditionsUKBB000005237.98
815Left-hemisphere dorsal attention network to putamen white-matter structural connectivityGCST903027037.97
816Internal derangement of knee (PheCode 835)GCST904762827.97
817APP/HBEGF ratioGCST903133247.92
818Red blood cell countGCST900187517.89
819ST13 levelsGCST904707517.87
820Myo-inositol levelsGCST902435277.87
821Neutrophil percentage of white cellsGCST0046337.87
822Acute upper respiratory infections of multiple and unspecified sitesFING000000357.87
823VCAM1 levelsGCST904710317.85
824CASP8/PPP3R1 ratioGCST903136547.85
825rfMRI connectivity (ICA100 edge 605)GCST900054587.84
826GRHPR levelsGCST904694007.82
827Polyp of the female genital tractFING000011907.82
828IDP dMRI TBSS OD Posterior limb of internal capsule LGCST900044217.82
829KeloidGCST900186547.81
830Dementia due to Parkinson's disease (more control exclusions)FING000003927.80
831Volume of left anterior amygdaloid areaGCST904749377.79
832IPCEF1/SPARC ratioGCST903151867.79
833DTI autoptx L2 slf l tractGCST903851877.78
834Pollen allergyFING000011767.78
835DTI TBSS MD Superior corona radiata RGCST903845967.77
836Restless legs syndromeGCST904353877.76
837CALCOCO1/IRAG2 ratioGCST903136047.75
838NELL2/SEZ6L ratioGCST903155367.74
839Kynurenine levelsGCST902434777.74
840PTP4A3 levelsGCST904703757.70
841Primary sclerosing cholangitisGCST0040307.69
842VNN2 levelsGCST904710447.65
843AXIN1/MAVS ratioGCST903134147.65
844BCR/ITGB1BP2 ratioGCST903134947.62
845CCS levelsGCST904685947.61
846NME3 levelsGCST904700557.60
847FKBP1B/PRDX5 ratioGCST903148337.60
848Spondylopathies (FG)FING000013267.59
849CA2/HMBS ratioGCST903135797.59
850BCR/FOXO1 ratioGCST903134907.59
851Sources of admission to hospital (recoded) - Usual Place of residence | Summary AdministrationUKBB000007867.57
852ITGB2 levelsGCST904696447.54
853Right-hemisphere control network to amygdala white-matter structural connectivityGCST903028417.53
854DLG4 levelsGCST904690017.53
855Bread type - Wholemeal or wholegrain | DietUKBB000001077.52
856GCHFR levelsGCST904693177.52
857Poultry consumptionGCST901329967.51
858CRYGD levelsGCST904688767.49
859Telomere length (principal component 1)GCST904351447.48
860BA-exvivo lh volume BA2GCST900028367.47
861Malignant neoplasm, excluding all cancers (controls excluding all cancers)FING000007807.45
862CCL13/CCL17 ratioGCST903136747.44
863Mean corpuscular haemoglobin | Blood countUKBB000004477.41
864Vertiginous syndromes and other disorders of vestibular system (PheCode 386)GCST904759057.40
865DTI TBSS MD Superior longitudinal fasciculus RGCST903846127.39
866Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levelsGCST900605577.38
867Bread type: Wholemeal or wholegrain (UKB data field 1448_3)GCST901329667.38
868DTI TBSS L1 Cingulum cingulate gyrus LGCST903844637.32
869Other obstetric traumaFING000010827.32
870Back pain (PheCode 760)GCST904762667.32
871Volume of right basal nucleusGCST904750157.30
872Plasma homoarginine levels in chronic kidney diseaseGCST902653457.30
873Other noninfective gastroenteritis and colitisFING000010777.28
874Omega-3 fatty acids to total fatty acids percentageGCST905020817.27
875White blood cell countGCST900024077.27
876Omega-3 fatty acid levelsGCST905020617.26
877FCER2/TNFRSF9 ratioGCST903147917.26
878ESAM/FUT8 ratioGCST903147117.25
879Blood cell traits latent factor 23 (white cell)GCST905592657.25
880Lipoma of skin and subcutaneous tissue (PheCode 214.1)GCST904756197.23
881NAP1L4 levelsGCST904699987.22
882Methods of admission to hospital (recoded) - Elective admission: Planned | Summary AdministrationUKBB000004627.21
883CD86 levelsGCST904686547.20
884CD274 levelsGCST902748327.19
885SNX15 levelsGCST904706997.18
886Mean corpuscular volume | Blood countUKBB000004497.18
887FUT8/VEGFC ratioGCST903148967.17
888White blood cell countGCST900023747.16
889SEMA4D levelsGCST904705737.13
890IDP dMRI TBSS FA Posterior limb of internal capsule RGCST900038957.13
891Hair colour (natural, before greying) - Blonde | Sun exposureUKBB000002967.13
892FOLR2/THY1 ratioGCST903148677.13
893CD22/FCRL1 ratioGCST903137577.13
894Percentage of FA2G1 in total neutral plasma glycans (GPn) (GP61)GCST906685057.11
895Late-onset myasthenia gravisGCST900934667.10
896FOXO3/SH2B3 ratioGCST903148817.08
897Tobacco use disorder | mental disordersUKBB000008247.05
898wg lh intensity-contrast rostralmiddlefrontalGCST900038187.04
899DTI autoptx L3 str r tractGCST903852177.03
900Interpolated Age of participant when non-cancer illness first diagnosed | Medical conditionsUKBB000003697.03
901UBXN1 levelsGCST904710047.02
902F2R/SNX9 ratioGCST903147367.00
903Principal component-derived dietary pattern 21GCST901330267.00
904Ectopic pregnancyFING000004876.99
905Phosphatidylcholine acyl-alkyl C36:4 levelsGCST902400726.98
906Pancreas iron contentGCST900166766.98
907Excessive vomiting in pregnancyFING000005236.96
908GPI levelsGCST904693916.95
909CA5A/GSTA1 ratioGCST903135916.95
910CCL5/SELP ratioGCST903137056.94
911Never eat wheat vs no wheat restrictions (UKB data field 6144)GCST901329326.94
912EDAR/SNAP23 ratioGCST903145876.93
913Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)FING000001436.91
914GMPR2 levelsGCST904693676.90
915TYRP1 levelsGCST904709986.90
916SIRT1 levelsGCST904706416.88
917Type 1 diabetes with ophthalmic manifestations (PheCode 250.13)GCST904756636.88
918F5 levelsGCST904464666.87
919Basophil countGCST900023796.87
920SNAP23/TXLNA ratioGCST903158576.86
921DAPP1/ITGB1BP2 ratioGCST903143886.86
922CC2D1A/TMSB10 ratioGCST903136676.85
923In your lifetime, have you smoked a total of at least 100 cigarettes?GCST904763876.84
924ThalamNuclei rh volume MGNGCST900027376.84
925DTI TBSS MD External capsule LGCST903846056.82
926T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101)GCST903209206.82
927Mood swings | Mental healthUKBB000004826.80
928Crohn's diseaseGCST904753186.80
929AK1 levelsGCST904682696.78
930YOD1 levelsGCST904710906.78
931CCL8 levelsGCST904223466.78
932CXCL11 levelsGCST904689246.77
933HLA-E levelsGCST904694596.77
934PDGFRA levelsGCST904210936.74
935DTI TBSS L3 Superior longitudinal fasciculus RGCST903845646.73
936O-sulfo-l-tyrosine levelsGCST902436236.72
937Other intervertebral disc disordersFING000010636.71
938FCRL5/TNFRSF13B ratioGCST903148056.69
939CALCOCO1/CRACR2A ratioGCST903135986.68
940HippSubfield lh volume Whole-hippocampal-bodyGCST900026876.68
941CD302/IL12A_IL12B ratioGCST903138066.68
942TNFSF14 levelsGCST904709226.68
943CALCOCO1/IKBKG ratioGCST903136026.67
944TBCB/TBCC ratioGCST903159096.67
945IL2RA levelsGCST904695856.67
946LBR levelsGCST904697446.66
947TOR1AIP1 levelsGCST904709356.66
948Volume of left central nucleusGCST904748836.65
949CDSN/WFDC12 ratioGCST903139996.64
950Operation code - hysterectomy | OperationsUKBB000005596.63
951Basal cell carcinoma, excluding all cancers (controls excluding all cancers)FING000001426.61
952JAM2/TNFRSF14 ratioGCST903152406.61
953Volume of right central nucleusGCST904750276.60
954FUT8 levelsGCST904692816.59
955Hemangioma of skin and subcutaneous tissue (PheCode 228.1)GCST904756336.58
956HippSubfield lh volume CA4-headGCST900026826.57
957All dysplastic lesions of the cervix uteriFING000000606.56
958Allergic conjunctivitisFING000000676.56
959NCR1 levelsGCST900901536.55
960AHCY/HSPA1A ratioGCST903132116.55
961T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 48)GCST903206116.54
962Degree of unsaturationGCST905022306.53
963Severity of induration at injection site at the injection site after COVID-19 booster vaccinationGCST904544096.53
964PPP1R14D levelsGCST904703036.52
965CLEC1B/HBEGF ratioGCST903140926.52
966CA1 levelsGCST904685106.52
967Pre-existing hypertension complicating pregnancy, childbirth and the puerperiumFING000012036.51
968BAG6/BMP6 ratioGCST903134506.50
969EDIL3 levelsGCST904690726.50
970Mucosal proctocolitisFING000008416.49
971LYN/SIRT2 ratioGCST903153496.49
972CD27/TNFRSF13B ratioGCST903137776.49
973EFNA4/TNFRSF9 ratioGCST903146066.46
974CCL5/TACC3 ratioGCST903137076.45
975red blood cell count (RBC, mean, inv-norm transformed)GCST904763476.45
976Ankylosing spondylitisFING000000896.44
977GSTA1/PBLD ratioGCST903149946.44
978ITGB1BP2/TIA1 ratioGCST903152226.44
979SUOX levelsGCST904707856.44
980Dermatomycosis (PheCode 110.2)GCST904755656.43
981Nervonoylcarnitine (C24:1) levelsGCST902001436.42
982LPCAT2/SERPINB8 ratioGCST903153286.42
983TNFRSF13B/TNFRSF9 ratioGCST903159326.42
984KIFBP/LYN ratioGCST903152466.41
985CD40LG/TNFSF14 ratioGCST903138276.41
986Pregnenolone sulfate levelsGCST901998736.39
987Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)FING000008466.39
988CASP10 levelsGCST904685426.39
989CCL4 levelsGCST900120526.38
990DTI autoptx MD slf r tractGCST903852426.38
991FOXO1/USP8 ratioGCST903148796.38
992Ingrowing nail (PheCode 703.1)GCST904762086.37
993Ulcerative colitis (strict) with PSCFING000013896.35
994Cervical disc disordersFING000002656.35
995Mental and behavioural disorders due to use of tobacco | Mental and behavioural disorders due to psychoactive substance useUKBB000004606.34
996Mean arterial pressure, manual reading | Cardiovascular measurementUKBB000004416.34
997TNFSF13B levelsGCST904709206.34
998CASP1 levelsGCST904685436.34
999DNMBP/WWP2 ratioGCST903145226.34
1000TYRO3 levelsGCST904709976.33